The historical rank and industry rank for Eckert & Ziegler SE's FCF Margin % or its related term are showing as below:
STU:EUZ'
s FCF Margin % Range Over the Past 10 Years
Min: 2.77 Med: 11.24 Max: 18.59
Current: 9.43
During the past 13 years, the highest FCF Margin % of Eckert & Ziegler SE was 18.59%. The lowest was 2.77%. And the median was 11.24%.
STU:EUZ's FCF Margin % is ranked better than 72.15% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: -0.03
vs STU:EUZ: 9.43
Eckert & Ziegler SE FCF Margin % Related Terms
Eckert & Ziegler SE FCF Margin % Historical Data
* Premium members only.
The historical data trend for Eckert & Ziegler SE's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Eckert & Ziegler SE's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Eckert & Ziegler SE FCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Eckert & Ziegler SE's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Eckert & Ziegler SE's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Eckert & Ziegler SE (STU:EUZ) has a FCF Margin % of -0.59% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Eckert & Ziegler SE and its competitors. Over the past decade, Eckert & Ziegler SE's FCF Margin % has ranged from 2.77 to 18.59. According to the industry distribution chart, Eckert & Ziegler SE ranks #227 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 27.9%.
Is Eckert & Ziegler SE's FCF Margin % too high?
Eckert & Ziegler SE's current FCF Margin % is -0.59%. Over the past 10 years, this metric has ranged from a low of 2.77 to a high of 18.59. Based on the distribution chart, Eckert & Ziegler SE ranks #227 out of 815 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Eckert & Ziegler SE has a GF Score™ of 98/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Eckert & Ziegler SE's FCF Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Eckert & Ziegler SE ranks #227 out of 815 companies for FCF Margin %. This puts Eckert & Ziegler SE in the upper half of its industry. Historically, Eckert & Ziegler SE's own FCF Margin % has ranged from 2.77 to 18.59 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Eckert & Ziegler SE and its competitors. Eckert & Ziegler SE's current FCF Margin % is -0.59%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eckert & Ziegler SE stock overvalued right now?
Based on GuruFocus' analysis, Eckert & Ziegler SE (STU:EUZ) is currently considered Fairly Valued. The stock's GF Value™ is €16.05, compared to a current price of €15.22 — trading 5.2% below its estimated fair value. The current FCF Margin % is -0.59%. Eckert & Ziegler SE's overall GF Score™ is 98/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Eckert & Ziegler SE (STU:EUZ), the current FCF Margin % is -0.59% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Eckert & Ziegler SE (STU:EUZ) Overvalued in 2026?
Based on GuruFocus' analysis, Eckert & Ziegler SE stock appears to be undervalued.
The current stock price of €15.22 is trading 5.2% below its estimated GF Value™ of €16.05.
GuruFocus considers Eckert & Ziegler SE to be Fairly Valued.
Key valuation signals for STU:EUZ:
FCF Margin %: -0.59%
GF Value™: €16.05 vs. price of €15.22 (5.2% below fair value)
No single metric tells the full story. See the STU:EUZ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Eckert & Ziegler SE is a holding company with specialised in the processing of radioisotopes and the development, production and sale of isotope technology components, radiopharmaceuticals and related products. It is an international manufacturer of isotope technology components for medical, scientific, and industrial applications. The group's products are mainly used in cancer therapy, nuclear imaging, and industrial metrology. The company's segments are Medical, Isotope Products, and Other. The majority of revenue comes from Medical segment which provides pharmaceutical-quality radioactive ingredients and markets products for the treatment and diagnosis of cancers. Geographically, the company generates a majority of its revenue from Europe and then North America, Asia/Pacific, and other.
98GF Score
Get the complete analysis for STU:EUZ
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:EUZ has been successfully added to your 
